Drug class

Lamivudine

Lamivudine is a specific antiretroviral active pharmaceutical ingredient rather than an independent therapeutic drug class; it belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs). Read more about Lamivudine

38 drugs in this class 24 manufacturers

Advertisement

Drugs in Lamivudine

Showing 1–9 of 38 drugs

EPIVIR (lamivudine)

ANTIVIRAL-HIV(ANTIRETROVIRAL) NUCLEOSIDE/-TIDE RT INHIBITORS · HIV INFECTION
VIIV HEALTHCARE

EPIVIR (lamivudine)

ANTIVIRAL-HIV(ANTIRETROVIRAL) NUCLEOSIDE/-TIDE RT INHIBITORS · HIV INFECTION
VIIV HEALTHCARE

LAMIVUDINE

ANTIVIRAL-HIV(ANTIRETROVIRAL) NUCLEOSIDE/-TIDE RT INHIBITORS · HIV INFECTION
APOTEX CORP

LAMIVUDINE

ANTIVIRAL-HIV(ANTIRETROVIRAL) NUCLEOSIDE/-TIDE RT INHIBITORS · HIV INFECTION
AUROBINDO PHARM

LAMIVUDINE

ANTIVIRAL-HIV(ANTIRETROVIRAL) NUCLEOSIDE/-TIDE RT INHIBITORS · HIV INFECTION
GSK Consumer Healthcare

LAMIVUDINE

ANTIVIRAL-HIV(ANTIRETROVIRAL) NUCLEOSIDE/-TIDE RT INHIBITORS · HIV INFECTION
AUROBINDO PHARM

LAMIVUDINE

ANTIVIRAL-HIV(ANTIRETROVIRAL) NUCLEOSIDE/-TIDE RT INHIBITORS · HIV INFECTION
Major Pharamceuticals
Filter & compare in the drug finder → Opens the drug finder with Lamivudine preselected. Add indication or manufacturer filters there.

About Lamivudine.

Lamivudine is a specific antiretroviral active pharmaceutical ingredient rather than an independent therapeutic drug class; it belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs).

As a synthetic cytosine analogue, it is phosphorylated intracellularly to its active 5'-triphosphate form, which competitively inhibits viral reverse transcriptase and hepatitis B virus DNA polymerase, causing viral DNA chain termination.

Therapeutically, it is used in combination regimens to manage human immunodeficiency virus type 1 (HIV-1) infection and as a single agent or component of therapy for chronic hepatitis B virus (HBV) infection.